KOTRA Stock Overview
An investment holding company, develops, manufactures, and trades in pharmaceutical and healthcare products in Malaysia. More details
| Snowflake Score | |
|---|---|
| Valuation | 5/6 |
| Future Growth | 2/6 |
| Past Performance | 2/6 |
| Financial Health | 6/6 |
| Dividends | 2/6 |
My Notes
Capture your thoughts, links and company narrative
Kotra Industries Berhad Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | RM 4.19 |
| 52 Week High | RM 5.12 |
| 52 Week Low | RM 3.90 |
| Beta | 0.15 |
| 1 Month Change | -5.63% |
| 3 Month Change | -2.56% |
| 1 Year Change | -12.34% |
| 3 Year Change | 16.39% |
| 5 Year Change | 93.98% |
| Change since IPO | 840.63% |
Recent News & Updates
Recent updates
Kotra Industries Berhad (KLSE:KOTRA) Has Announced A Dividend Of MYR0.13
Aug 21
Kotra Industries Berhad (KLSE:KOTRA) Is Paying Out A Larger Dividend Than Last Year
Feb 27Kotra Industries Berhad (KLSE:KOTRA) Is Increasing Its Dividend To MYR0.16
Oct 10Estimating The Fair Value Of Kotra Industries Berhad (KLSE:KOTRA)
Sep 16Kotra Industries Berhad (KLSE:KOTRA) Is Increasing Its Dividend To RM0.095
Feb 27Is Kotra Industries Berhad (KLSE:KOTRA) A Smart Choice For Dividend Investors?
May 05Does Kotra Industries Berhad (KLSE:KOTRA) Have A Healthy Balance Sheet?
Mar 24Be Sure To Check Out Kotra Industries Berhad (KLSE:KOTRA) Before It Goes Ex-Dividend
Mar 03Should You Rely On Kotra Industries Berhad's (KLSE:KOTRA) Earnings Growth?
Feb 21Shareholders Of Kotra Industries Berhad (KLSE:KOTRA) Must Be Happy With Their 191% Total Return
Feb 08How Does Kotra Industries Berhad (KLSE:KOTRA) Stand Up To These Simple Dividend Safety Checks?
Jan 26Declining Stock and Solid Fundamentals: Is The Market Wrong About Kotra Industries Berhad (KLSE:KOTRA)?
Jan 13
Do Kotra Industries Berhad's (KLSE:KOTRA) Earnings Warrant Your Attention?
Dec 31Is Kotra Industries Berhad (KLSE:KOTRA) A Risky Investment?
Dec 18Is Kotra Industries Berhad's (KLSE:KOTRA) Shareholder Ownership Skewed Towards Insiders?
Dec 05Kotra Industries Berhad (KLSE:KOTRA) Looks Like A Good Stock, And It's Going Ex-Dividend Soon
Nov 22Is There More To The Story Than Kotra Industries Berhad's (KLSE:KOTRA) Earnings Growth?
Nov 20Shareholder Returns
| KOTRA | MY Pharmaceuticals | MY Market | |
|---|---|---|---|
| 7D | 2.2% | 0.9% | -2.0% |
| 1Y | -12.3% | -9.6% | 3.3% |
Return vs Industry: KOTRA underperformed the MY Pharmaceuticals industry which returned -9.6% over the past year.
Return vs Market: KOTRA underperformed the MY Market which returned 3.3% over the past year.
Price Volatility
| KOTRA volatility | |
|---|---|
| KOTRA Average Weekly Movement | 4.1% |
| Pharmaceuticals Industry Average Movement | 3.6% |
| Market Average Movement | 5.0% |
| 10% most volatile stocks in MY Market | 10.3% |
| 10% least volatile stocks in MY Market | 2.5% |
Stable Share Price: KOTRA has not had significant price volatility in the past 3 months compared to the MY market.
Volatility Over Time: KOTRA's weekly volatility (4%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1982 | 655 | Jimmy Piong | www.kotrapharma.com |
Kotra Industries Berhad, an investment holding company, develops, manufactures, and trades in pharmaceutical and healthcare products in Malaysia. The company provides nutraceutical products, including various health supplement products under the Appeton brand for children, expectant mothers, and seniors. It also offers various pharmaceutical products in the areas of pediatric care, anti-infective, gastroenterology, and dermatology under the Axcel brand; sterile antibiotic injectables under the Vaxcel brand; asthma control products under the Arite brand; and fungal infection treatment products under the Creobic brand.
Kotra Industries Berhad Fundamentals Summary
| KOTRA fundamental statistics | |
|---|---|
| Market cap | RM 621.44m |
| Earnings (TTM) | RM 40.67m |
| Revenue (TTM) | RM 238.84m |
15.3x
P/E Ratio2.6x
P/S RatioIs KOTRA overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| KOTRA income statement (TTM) | |
|---|---|
| Revenue | RM 238.84m |
| Cost of Revenue | RM 74.21m |
| Gross Profit | RM 164.63m |
| Other Expenses | RM 123.96m |
| Earnings | RM 40.67m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.27 |
| Gross Margin | 68.93% |
| Net Profit Margin | 17.03% |
| Debt/Equity Ratio | 0% |
How did KOTRA perform over the long term?
See historical performance and comparisonDividends
6.1%
Current Dividend Yield139%
Payout RatioCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/01/30 04:01 |
| End of Day Share Price | 2025/01/28 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2024/06/30 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Kotra Industries Berhad is covered by 7 analysts. 3 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Dharmini Thuraisingam | CGS International |
| Cheng Wei Lew | CGS International |
| Ping-Khoon Choo | Kenanga Research |